查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881732

生物植入物市場－全球產業規模、佔有率、趨勢、機會和預測，依產品、應用、地區和競爭格局分類，2020-2030年預測

Biological Implants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By region, and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球生物植入物市場規模將從2024年的85.4億美元成長到2030年的124.2億美元，年複合成長率（CAGR）為6.44%。生物植入物是指利用生物相容性材料植入體內或體外，用於取代、支持或增強生物功能的醫療器材。推動市場擴張的主要因素包括：全球人口老化導致修復手術需求增加，以及心血管疾病和骨關節炎等慢性疾病的日益普遍。

市場概覽
預測期 2026-2030
2024年市場規模 85.4億美元
2030年市場規模 124.2億美元
2025-2030年複合年成長率 6.44%
成長最快的細分市場 異種移植
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球生物植入物市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品分類（自體移植、同種異體移植、異種移植）
    • 依應用領域（心血管植入物、骨科植入物、其他軟組織植入物）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美生物植入物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲生物植入物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太生物植入物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲生物植入物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲生物植入物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球生物植入物市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Integra LifeSciences Corporation
  • NuVasive, Inc.
  • Edwards Lifesciences Corporation
  • Stryker Corp.
  • LifeCell International Pvt. Ltd.
  • Medtronic Plc
  • Osteotec Limited
  • BioPolymer GmbH & Co KG
  • Johnson & Johnson Services, Inc
  • Baxter International Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 21685

The Global Biological Implants Market will grow from USD 8.54 Billion in 2024 to USD 12.42 Billion by 2030 at a 6.44% CAGR. Biological implants are medical devices placed inside or on the body to replace, support, or enhance biological functions, utilizing biocompatible materials. The market's expansion is fundamentally driven by an aging global population requiring a greater number of restorative procedures, coupled with the increasing prevalence of chronic diseases such as cardiovascular conditions and osteoarthritis.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 8.54 Billion
Market Size 2030USD 12.42 Billion
CAGR 2025-20306.44%
Fastest Growing SegmentXenografts
Largest MarketNorth America

Key Market Drivers

Technological advancements in biomaterials and manufacturing fundamentally reshape the capabilities of biological implants, leading to products that offer superior integration, longevity, and patient-specific solutions. Ongoing research in advanced biomaterials, including novel polymers and surface-modified metals, enhances biocompatibility and functionality, thereby reducing adverse reactions and improving implant performance. Advanced manufacturing techniques, particularly 3D printing, enable the creation of highly customized implants with intricate designs that closely mimic natural biological structures, fostering better osseointegration and tissue regeneration.

Key Market Challenges

The complex and often prolonged regulatory approval processes represent a significant impediment to the expansion of the global biological implants market. These stringent requirements impose substantial financial burdens and extend development timelines for manufacturers. The necessity to adhere to evolving regulations, particularly evident in regions with advanced regulatory frameworks, escalates costs associated with clinical evaluations, post-market surveillance, and certification. This increased regulatory load directly curtails manufacturers' ability to allocate resources to research and development of novel biological implants.

Key Market Trends

A key trend is the increased focus on regenerative bio-implants, which aim to restore, replace, or regenerate damaged tissues and organs through biological mechanisms, moving beyond mere mechanical replacement. This involves developing implants that integrate advanced biomaterials with cellular components or growth factors to actively stimulate the body's natural healing processes. For instance, REGENXBIO Inc. and Nippon Shinyaku Co., Ltd. announced a strategic partnership in January 2025 for the development and commercialization of gene therapies, with REGENXBIO receiving $110 million upfront and up to an additional $700 million in potential milestones. This significant investment, as reported by Contract Pharma, January 15, 2025, in "Regenxbio, Nippon Shinyaku Partner for MPS II, MPS I Gene Therapies," highlights the market's trajectory towards biological solutions that foster genuine tissue regeneration.

Key Market Players

  • Integra LifeSciences Corporation
  • NuVasive, Inc.
  • Edwards Lifesciences Corporation
  • Stryker Corp.
  • LifeCell International Pvt. Ltd.
  • Medtronic Plc
  • Osteotec Limited
  • BioPolymer GmbH & Co KG
  • Johnson & Johnson Services, Inc
  • Baxter International Inc.

Report Scope:

In this report, the Global Biological Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biological Implants Market, By Product:

  • Autografts
  • Allografts
  • Xenografts

Biological Implants Market, By Application:

  • Cardiovascular Implants
  • Orthopedic Implants
  • Others Soft Tissue Implants

Biological Implants Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biological Implants Market.

Available Customizations:

Global Biological Implants Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biological Implants Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Autografts, Allografts, Xenografts)
    • 5.2.2. By Application (Cardiovascular Implants, Orthopedic Implants, Others Soft Tissue Implants)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Biological Implants Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biological Implants Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Biological Implants Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Biological Implants Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application

7. Europe Biological Implants Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Biological Implants Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
    • 7.3.2. France Biological Implants Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Biological Implants Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Biological Implants Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Biological Implants Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application

8. Asia Pacific Biological Implants Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Biological Implants Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
    • 8.3.2. India Biological Implants Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Biological Implants Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Biological Implants Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Biological Implants Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application

9. Middle East & Africa Biological Implants Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Biological Implants Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Biological Implants Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Biological Implants Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application

10. South America Biological Implants Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Biological Implants Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Biological Implants Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Biological Implants Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Biological Implants Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Integra LifeSciences Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. NuVasive, Inc.
  • 15.3. Edwards Lifesciences Corporation
  • 15.4. Stryker Corp.
  • 15.5. LifeCell International Pvt. Ltd.
  • 15.6. Medtronic Plc
  • 15.7. Osteotec Limited
  • 15.8. BioPolymer GmbH & Co KG
  • 15.9. Johnson & Johnson Services, Inc
  • 15.10. Baxter International Inc.

16. Strategic Recommendations

17. About Us & Disclaimer